Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT)

International Journal of Cardiology

Volumn 137, Issue 1, 2009, Pages 16-21

  Meliga, E ^a,b   Garcia Garcia, H M ^a   Valgimigli, M ^c   Chieffo, A ^d   Biondi Zoccai, G ^b   Maree, A O ^e   Gonzalo, N ^a   Cook, S ^f   Marra, S ^b   Moretti, C ^b   De Servi, S ^g   Palacios, I F ^e   Windecker, S ^f   van Domburg, R ^a   Colombo, A ^d   Sheiban, I ^b   Serruys, P W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f BERN UNIVERSITY HOSPITAL   (Switzerland)

^g Ospedale Civile di Legnano   (Italy)

Author keywords

Paclitaxel eluting stent; Percutaneous coronay intervention; Sirolimus eluting stent; Unprotected left main coronary artery disease

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PACLITAXEL; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; EUROPE; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; LEFT CORONARY ARTERY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STENT THROMBOSIS; SURVIVAL RATE; TERTIARY HEALTH CARE; THERAPY EFFECT; UNITED STATES; UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE; UNPROTECTED LEFT MAIN CORONARY ARTERY STENOSIS;

AGED; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; REGISTRIES; RETROSPECTIVE STUDIES; SIROLIMUS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 68949167532     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.06.006     Document Type: Article

References (19)

1. Valgimigli M., van Mieghem C.A., Ong A.T., Aoki J., et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated at Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation 111 11 (2005) 1383-1389
2. Valgimigli M., Malagutti P., Rodriguez Granillo G.A., et al. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries. Am Heart J 152 5 (2006) 896-902
3. Sheiban I., Meliga E., Moretti C., et al. Long-term clinical and angiographic outcomes of treatment of unprotected left main coronary artery stenosis with sirolimus-eluting stents. Am J Cardiol 100 3 (2007) 431-435
4. Park S.J., Kim Y.H., Lee B.K., et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 45 3 (2005) 351-356
5. Chieffo A., Park S.J., Valgimigli M., et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. Circulation 116 2 (2007) 158-162
6. Valgimigli M., Malagutti P., Rodriguez-Granillo G.A., et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries. J Am Coll Cardiol 47 8 (2006) 1530-1537
7. Baim D.S., Mauri L., and Cutlip D.C. Drug-eluting stenting for unprotected left main coronary artery disease: are we ready to replace bypass surgery?. J Am Coll Cardiol 47 4 (2006) 878-881
8. Kereiakes D.J. The Emperor's new clothes: another cypher versus taxus post-hoc meta-analysis. J Am Coll Cardiol 50 14 (2007) 1381-1385
9. Schomig A., Dibra A., Windecker S., et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 50 14 (2007) 1373-1380
10. Windecker S., Remondino A., Eberli F.R., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 7 (2005) 653-662
11. Morice M.C., Colombo A., Meier B., et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. Jama 295 8 (2006) 895-904
12. Pan M., Suarez de Lezo J., Medina A., et al. Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. Am Heart J 153 1 (2007) 15 e11-17
13. Togni M., Eber S., Widmer J., et al. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. J Am Coll Cardiol 50 12 (2007) 1123-1131
14. Kim Y.H., Park S.W., Lee S.W., et al. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation 114 20 (2006) 2148-2153
15. Valgimigli M., Malagutti P., Aoki J., et al. Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis. J Am Coll Cardiol 47 3 (2006) 507-514
16. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 14 (2003) 1315-1323
17. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 3 (2004) 221-231
18. Aoki J., Abizaid A.C., Serruys P.W., et al. Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol 46 9 (2005) 1670-1676
19. Tsuchida K., Serruys P.W., Bruining N., et al. Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial. Am J Cardiol 99 5 (2007) 607-615